RxDoctor Payments Data

Jill Campbell

Family · Shenandoah, TXNPI 1164023461

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $165,860 of the $181,808 with a category attached, or 91.2%. AbbVie accounts for 64.9% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2024 at $83,133 and has fallen 52.4% since, to $39,576 in 2025. Among family clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$181,808in general payments, 2019–2025

Across 284 payments — averaging $640.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$118K
  • Galderma Laboratories, L.p.$63K
  • Merz North America, Inc.$998
  • Revance Therapeutics, Inc.$34

What the payments were for

  • Speaking & faculty fees$165,86091%
  • Travel & lodging$9,7345%
  • Food & beverage$6,1403%
  • Education$730%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)192$118,034
Galderma Laboratories, L.p.80$62,741
Merz North America, Inc.11$998
Revance Therapeutics, Inc.1$34

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$181,808 in reported general payments places this provider in the 95th percentile of 15,456 family providers in Texas.

See all family providers in Texas →

Other family in Shenandoah

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →